Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Benjamin L. Ebert, Michael E. Birnbaum et al.|Science Translational Medicine|2021Cited by 257
Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic MalignanciesAline Renneville, Benjamin L. Ebert, Sophie Cotteret et al.|Blood Cancer Discovery|2021Cited by 46
Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen ReceptorsMax Jan, Benjamin L. Ebert, Ana P. Castaño et al.|Blood|2019Cited by 0